Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use

Overview publication

TitleHeterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use
DateJuly 1st, 2023
Issue nameGenetics in Medicine
Issue numberv25.7 p100857
DOI10.1016/j.gim.2023.100857
AuthorsLe Collen L, Delemer B, Poitou C, Vaxillaire M, Toussaint B, Dechaume A, Badreddine A, Boissel M, Derhourhi M, Clément K, Petit JM, Mau-Them FT, Bruel A, Thauvin-Robinet C, Saveanu A, Cherifi BG, Le Beyec-Le Bihan J, Froguel P & Bonnefond A
MTGsMTG5
Read Read publication